Tracking Cathie Wood's ARK Invest 13F Portfolio - Q1 2026 Update

Seeking Alpha - Tue, 05/12/2026 - 22:54

Hyperfine targets $20M-$22M 2026 revenue while maintaining 50%-55% gross margin

Seeking Alpha - Tue, 05/12/2026 - 22:41

GrowGeneration expects $42M-$44M Q2 revenue while targeting ~breakeven adjusted EBITDA for 2026

Seeking Alpha - Tue, 05/12/2026 - 22:41

Rocket Lab's Rally Changes Everything For Investors

Seeking Alpha - Tue, 05/12/2026 - 22:34

SideChannel outlines August 2026 phase 2 shift as Enclave First targets 64% to 75% margin potential

Seeking Alpha - Tue, 05/12/2026 - 22:32

Thrivent Government Bond Fund Q1 2026 Commentary

Seeking Alpha - Tue, 05/12/2026 - 22:30

20Wickets: Easy Registration, Secure Payments & Fast Withdrawals

TalkMarkets - Tue, 05/12/2026 - 22:29
20Wickets: Easy Registration, Secure Payments & Fast Withdrawals

Markets Eye Stability as Trump and Xi Meet

TalkMarkets - Tue, 05/12/2026 - 22:22
Markets Eye Stability as Trump and Xi Meet

Madison Diversified Income Fund Q1 2026 Investment Strategy Letter

Seeking Alpha - Tue, 05/12/2026 - 22:20

Velo3D reiterates $60M-$70M 2026 revenue outlook while targeting gross margins above 30% in 2H

Seeking Alpha - Tue, 05/12/2026 - 22:11

Parks! America outlines up to $0.5m in digital signage spend as CEO flags March macro headwind

Seeking Alpha - Tue, 05/12/2026 - 22:02

Monex Group, Inc. 2026 Q4 - Results - Earnings Call Presentation

Seeking Alpha - Tue, 05/12/2026 - 22:02

D-Wave Quantum Inc. 2026 Q1 - Results - Earnings Call Presentation

Seeking Alpha - Tue, 05/12/2026 - 22:01

Capricor outlines deramiocel PDUFA date of August 22, 2026 while targeting 2,000 to 2,500 patients per year manufacturing capacity

Seeking Alpha - Tue, 05/12/2026 - 21:51

Xometry Beats The Odds: Growth Further Accelerates Despite Tough Comps

Seeking Alpha - Tue, 05/12/2026 - 21:51

Healthpeak Properties: Lab Weakness Creates A Major Re-Rating Opportunity

Seeking Alpha - Tue, 05/12/2026 - 21:45

The Swatch Group: The Price Recovery Can Continue

Seeking Alpha - Tue, 05/12/2026 - 21:18

Andersen expects $980M-$1B 2026 revenue while raising inorganic revenue outlook to $55M

Seeking Alpha - Tue, 05/12/2026 - 21:11

Neuropace signals $99M-$101M 2026 revenue outlook while targeting 21%-23% underlying RNS growth

Seeking Alpha - Tue, 05/12/2026 - 21:11

Atea Pharmaceuticals, Inc. 2026 Q1 - Results - Earnings Call Presentation

Seeking Alpha - Tue, 05/12/2026 - 21:02

Pages